RELATIONSHIP OF INTERLEUKIN-1-BETA AND BETA(2)-MICROGLOBULIN WITH NEUROPEPTIDES IN CEREBROSPINAL-FLUID OF PATIENTS WITH DEMENTIA OF THE ALZHEIMER-TYPE

被引:36
|
作者
MARTINEZ, M
FRANK, A
HERNANZ, A
机构
[1] HOSP LA PAZ INSALUD,SERV BIOQUIM,CASTELLANA 261,E-28046 MADRID,SPAIN
[2] HOSP LA PAZ INSALUD,SERV NEUROL,E-28046 MADRID,SPAIN
关键词
INTERLEUKIN-1-BETA; BETA(2)-MICROGLOBULIN; NEUROPEPTIDES; CEREBROSPINAL FLUID; ALZHEIMERS DISEASE; MULTIINFARCT DEMENTIA;
D O I
10.1016/0165-5728(93)90197-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We studied interleukin-1beta (IL-1beta), beta2-MiCroglobulin (beta2-M), beta-endorphin, substance P, neuropeptide Y and somatostatin concentrations in the cerebrospinal fluid of 13 patients with dementia of the Alzheimer type (DAT), 13 patients with multi-infarct dementia (MID) and 15 age-matched control subjects. Substance P was significantly lower in DAT than in controls (P < 0.05), as well as somatostatin in DAT as compared to both controls (P < 0.01) and MID (P < 0.05), whereas beta2-M was higher in DAT than in controls (P < 0.01). Neuropeptide Y, beta-endorphin and IL-1beta showed similar concentrations in the three groups studied. A significantly positive correlation was observed between IL-1beta and substance P (r = 0.79, P < 0.01) and somatostatin (r = 0.75, P < 0.05) in DAT, which was not observed in MID. In addition, beta2-M showed a negative correlation with IL-1beta (r = -0.73, P < 0.05) in DAT, and age correlated negatively with IL-1beta in controls and MID, but positively in DAT. Therefore, these results support the idea that an altered relationship may exist in Alzheimer's disease between the nervous and immune system.
引用
收藏
页码:235 / 240
页数:6
相关论文
共 50 条
  • [1] DECREASED INTERLEUKIN-6 LEVEL IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMER-TYPE DEMENTIA
    YAMADA, K
    KONO, K
    UMEGAKI, H
    YAMADA, K
    IGUCHI, A
    FUKATSU, T
    NAKASHIMA, N
    NISHIWAKI, H
    SHIMADA, Y
    SUGITA, Y
    YAMAMOTO, T
    HASEGAWA, T
    NABESHIMA, T
    [J]. NEUROSCIENCE LETTERS, 1995, 186 (2-3) : 219 - 221
  • [2] ENZYMATIC CHANGES IN CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMER-TYPE DEMENTIA
    AOYAGI, T
    WADA, T
    KOJIMA, F
    NAGAI, M
    HARADA, S
    TAKEUCHI, T
    ISSE, K
    OGURA, M
    HAMAMOTO, M
    TANAKA, K
    NAGAO, T
    [J]. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 1993, 14 (02) : 133 - 139
  • [3] BETA2-MICROGLOBULIN IN CEREBROSPINAL-FLUID
    STARMANS, HJJP
    VOS, J
    VANDERHELM, HJ
    [J]. JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1977, 15 (03): : 188 - 188
  • [4] PEPTIDE HISTIDINE METHIONINE IN CEREBROSPINAL-FLUID OF PATIENTS WITH SENILE DEMENTIA OF THE ALZHEIMER-TYPE
    YASUDA, M
    MINAMITANI, N
    MAEDA, K
    [J]. JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY, 1993, 47 (01): : 85 - 90
  • [5] PLASMA AND CEREBROSPINAL-FLUID INTERLEUKIN-1-BETA INTERLEUKIN-6 IN HOSPITALIZED SCHIZOPHRENIC-PATIENTS
    KATILA, H
    HURME, M
    WAHLBECK, K
    APPELBERG, B
    RIMON, R
    [J]. NEUROPSYCHOBIOLOGY, 1994, 30 (01) : 20 - 23
  • [6] TAU-PROTEIN CONCENTRATIONS IN CEREBROSPINAL-FLUID OF PATIENTS WITH DEMENTIA OF THE ALZHEIMER-TYPE
    TATO, RE
    FRANK, A
    HERNANZ, A
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 59 (03): : 280 - 283
  • [7] BETA2-MICROGLOBULIN IN CEREBROSPINAL-FLUID IN NEUROLOGY
    BEYNE, P
    LISOVOSKI, F
    GOT, L
    AYACHE, P
    DELACOUX, E
    [J]. PRESSE MEDICALE, 1995, 24 (23): : 1071 - 1074
  • [8] PANCREASTATIN-LIKE IMMUNOREACTIVITY OF CEREBROSPINAL-FLUID IN PATIENTS WITH ALZHEIMER-TYPE DEMENTIA - EVIDENCE OF ABERRANT PROCESSING OF PANCREASTATIN IN ALZHEIMER-TYPE DEMENTIA
    SEKIYA, K
    HAJI, M
    FUKAHORI, M
    TAKAYANAGI, R
    OHASHI, M
    KUROSE, SN
    OYAMA, M
    TATEISHI, K
    FUNAKOSHI, A
    NAWATA, H
    [J]. NEUROSCIENCE LETTERS, 1994, 177 (1-2) : 123 - 126
  • [9] CEREBROSPINAL-FLUID INTERLEUKIN-1-BETA (IL-1-BETA) IN ALZHEIMERS-DISEASE AND NEUROLOGICAL DISORDERS
    CACABELOS, R
    BARQUERO, M
    GARCIA, P
    ALVAREZ, XA
    DESEIJAS, EV
    [J]. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1991, 13 (07): : 455 - 458
  • [10] REMARKABLE REDUCTION IN ACETYLCHOLINE CONCENTRATION IN THE CEREBROSPINAL-FLUID FROM PATIENTS WITH ALZHEIMER-TYPE DEMENTIA
    TOHGI, H
    ABE, T
    HASHIGUCHI, K
    SAHEKI, M
    TAKAHASHI, S
    [J]. NEUROSCIENCE LETTERS, 1994, 177 (1-2) : 139 - 142